Archivos en Investigación del Cáncer

  • ISSN: 2254-6081
  • Índice h de la revista: 13
  • Puntuación de cita de revista: 3.58
  • Factor de impacto de la revista: 3.12
Indexado en
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • CiteFactor
  • OCLC-WorldCat
  • Publón
  • Fundación de Ginebra para la Educación e Investigación Médica
  • Google Académico
  • Laboratorios secretos de motores de búsqueda
Comparte esta página

Abstracto

Frankincense (Boswellia Species): The Novel Phytotherapy for Drug Targeting in Cancer

Rafie Hamidpour, Soheila Hamidpour, Mohsen Hamidpour and Roxanna Hamidpour

It seems that frankincense might have a potential ability to be used as an alternative natural medicine not only for cancer, chronic and inflammatory diseases but also for the patients with brain and memory disorders. Frankincense, the resinous extract from the trees of the genus Boswellia, has been used for centuries in ceremonial, cosmetic, cultural and as a traditional medicine to treat a variety of ailments especially cancer, inflammatory diseases including asthma, arthritis, cerebral edema, chronic pain syndrome, chronic bowel diseases, and some other illnesses. Boswellic acids are the active compounds of frankincense and AKBA (3-O-acetyl-11-keto-β-boswellic acid) is the most important and effective acid among them. Some studies have shown that the use of frankincense can also improve the learning and enhance the memory in animals and human.